Suppr超能文献

胃旁路手术联合运动可改变血浆微小RNA,这些微小RNA可预测心血管代谢风险的改善情况。

Gastric bypass surgery with exercise alters plasma microRNAs that predict improvements in cardiometabolic risk.

作者信息

Nunez Lopez Y O, Coen P M, Goodpaster B H, Seyhan A A

机构信息

Translational Research Institute for Metabolism and Diabetes, Florida Hospital, Orlando, FL, USA.

Sanford Burnham Prebys Medical Discovery Institute, Lake Nona, FL, USA.

出版信息

Int J Obes (Lond). 2017 Jul;41(7):1121-1130. doi: 10.1038/ijo.2017.84. Epub 2017 Mar 27.

Abstract

BACKGROUND/OBJECTIVES: Roux-en-Y gastric bypass (RYGB) surgery improves insulin sensitivity (S) and β-cell function in obese non-diabetic subjects. Exercise also improves S and may be an effective adjunct therapy to RYGB surgery. However, the mechanisms by which exercise or weight loss improve peripheral S after RYGB surgery are unclear. We hypothesized that microRNAs (miRNAs) mediate at least some of the regulatory processes driving such mechanisms. Consequently, this work aimed at profiling plasma miRNAs in participants of the Physical Activity Following Surgery Induced Weight Loss study (clinicaltrials.gov identifier: NCT00692367), to assess whether miRNA levels track with improvements in S and cardiometabolic risk factors.

SUBJECTS/METHODS: Ninety-four miRNAs implicated in metabolism were profiled in plasma samples from 22 severely obese subjects who were recruited 1-3 months after RYGB surgery and followed for 6 months of RYGB surgery-induced weight loss, with (exercise program (EX), N=11) or without (CON, N=11) an exercise training intervention. The subjects were selected, considering a priori sample size calculations, among the participants in the parent study. Mixed-effect modeling for repeated measures and partial correlation analysis was implemented in the R environment for statistical analysis.

RESULTS

Mirroring results in the parent trial, both groups experienced significant weight loss and improvements in cardiometabolic risk. In the CON group, weight loss significantly altered the pattern of circulating miR-7, miR-15a, miR-34a, miR-106a, miR-122 and miR-221. In the EX group, a distinct miRNA signature was altered: miR-15a, miR-34a, miR-122, miR-135b, miR-144, miR-149 and miR-206. Several miRNAs were significantly associated with improvements in acute insulin response, S, and other cardiometabolic risk factors.

CONCLUSIONS

These findings present novel insights into the RYGB surgery-induced molecular changes and the effects of mild exercise to facilitate and/or maintain the benefits of a 'comprehensive' weight-loss intervention with concomitant improvements in cardiometabolic functions. Notably, we show a predictive value for miR-7, miR-15a, miR-106b and miR-135b.

摘要

背景/目的:Roux-en-Y胃旁路术(RYGB)可改善肥胖非糖尿病患者的胰岛素敏感性(S)和β细胞功能。运动也能改善胰岛素敏感性,可能是RYGB手术的一种有效辅助治疗方法。然而,运动或体重减轻改善RYGB术后外周胰岛素敏感性的机制尚不清楚。我们推测,微小RNA(miRNA)至少介导了驱动这些机制的部分调节过程。因此,本研究旨在对手术诱导体重减轻后体育活动研究(clinicaltrials.gov标识符:NCT00692367)参与者的血浆miRNA进行分析,以评估miRNA水平是否与胰岛素敏感性及心血管代谢危险因素的改善情况相关。

对象/方法:对22名严重肥胖患者的血浆样本中的94种与代谢相关的miRNA进行分析。这些患者在RYGB手术后1 - 3个月入组,在RYGB手术诱导的体重减轻过程中随访6个月,其中一组(运动组,EX,N = 11)接受运动训练干预,另一组(对照组,CON,N = 11)不接受运动训练干预。根据预先计算的样本量,从母研究的参与者中选择这些受试者。在R环境中进行重复测量的混合效应模型和偏相关分析,以进行统计分析。

结果

与母试验结果一致,两组患者均出现显著体重减轻和心血管代谢危险因素改善。在对照组中,体重减轻显著改变了循环miR - 7、miR - 15a、miR - 34a、miR - 106a、miR - 122和miR - 221的模式。在运动组中,一组不同的miRNA特征发生改变:miR - 15a、miR - 34a、miR - 122、miR - 135b、miR - 144、miR - 149和miR - 206。几种miRNA与急性胰岛素反应、胰岛素敏感性及其他心血管代谢危险因素的改善显著相关。

结论

这些发现为RYGB手术诱导的分子变化以及轻度运动促进和/或维持“综合”减肥干预并伴随心血管代谢功能改善的效果提供了新的见解。值得注意的是,我们显示了miR - 7、miR - 15a、miR - 106b和miR - 135b的预测价值。

相似文献

1
Gastric bypass surgery with exercise alters plasma microRNAs that predict improvements in cardiometabolic risk.
Int J Obes (Lond). 2017 Jul;41(7):1121-1130. doi: 10.1038/ijo.2017.84. Epub 2017 Mar 27.
2
Dose response of exercise training following roux-en-Y gastric bypass surgery: A randomized trial.
Obesity (Silver Spring). 2015 Dec;23(12):2454-61. doi: 10.1002/oby.21332. Epub 2015 Nov 5.
3
Clinical trial demonstrates exercise following bariatric surgery improves insulin sensitivity.
J Clin Invest. 2015 Jan;125(1):248-57. doi: 10.1172/JCI78016. Epub 2014 Dec 1.
4
Role of microRNAs in the treatment of type 2 diabetes mellitus with Roux-en-Y gastric bypass.
Braz J Med Biol Res. 2017 Mar 2;50(3):e5817. doi: 10.1590/1414-431X20175817.
7
Roux-en-Y-Bariatric Surgery Reduces Markers of Metabolic Syndrome in Morbidly Obese Patients.
Obes Surg. 2020 Feb;30(2):391-400. doi: 10.1007/s11695-019-04190-y.
8
Supervised Physical Training Improves Weight Loss After Roux-en-Y Gastric Bypass Surgery: A Randomized Controlled Trial.
Obesity (Silver Spring). 2018 May;26(5):828-837. doi: 10.1002/oby.22143. Epub 2018 Mar 22.
9
Targeting the circulating microRNA signature of obesity.
Clin Chem. 2013 May;59(5):781-92. doi: 10.1373/clinchem.2012.195776. Epub 2013 Feb 8.

引用本文的文献

1
Circulating Liquid Biopsy Biomarkers in Glioblastoma: Advances and Challenges.
Int J Mol Sci. 2024 Jul 21;25(14):7974. doi: 10.3390/ijms25147974.
2
Early changes of microRNAs in blood one month after bariatric surgery.
Diabetol Metab Syndr. 2024 Jul 15;16(1):163. doi: 10.1186/s13098-024-01364-2.
3
Trials and Tribulations of MicroRNA Therapeutics.
Int J Mol Sci. 2024 Jan 25;25(3):1469. doi: 10.3390/ijms25031469.
4
Extracellular microRNAs in Relation to Weight Loss-A Systematic Review and Meta-Analysis.
Noncoding RNA. 2023 Sep 14;9(5):53. doi: 10.3390/ncrna9050053.
5
Circulating microRNAs as Potential Biomarkers in Pancreatic Cancer-Advances and Challenges.
Int J Mol Sci. 2023 Aug 28;24(17):13340. doi: 10.3390/ijms241713340.
8
Associations of maternal and placental extracellular vesicle miRNA with preeclampsia.
Front Cell Dev Biol. 2023 Feb 22;11:1080419. doi: 10.3389/fcell.2023.1080419. eCollection 2023.
9
Mechanisms and Outcomes of Metabolic Surgery in Type 2 Diabetes.
Metabolites. 2022 Nov 17;12(11):1134. doi: 10.3390/metabo12111134.
10
Weight loss reduces circulating micro-RNA related to obesity and breast cancer in postmenopausal women.
Epigenetics. 2022 Dec;17(13):2082-2095. doi: 10.1080/15592294.2022.2107841. Epub 2022 Aug 8.

本文引用的文献

2
The potential of endurance exercise-derived exosomes to treat metabolic diseases.
Nat Rev Endocrinol. 2016 Sep;12(9):504-17. doi: 10.1038/nrendo.2016.76. Epub 2016 May 27.
3
Circulating microRNAs predict future fatal myocardial infarction in healthy individuals - The HUNT study.
J Mol Cell Cardiol. 2016 Aug;97:162-8. doi: 10.1016/j.yjmcc.2016.05.009. Epub 2016 May 15.
4
Association of Circulating Serum miR-34a and miR-122 with Dyslipidemia among Patients with Non-Alcoholic Fatty Liver Disease.
PLoS One. 2016 Apr 14;11(4):e0153497. doi: 10.1371/journal.pone.0153497. eCollection 2016.
7
MicroRNAs as regulators of metabolic disease: pathophysiologic significance and emerging role as biomarkers and therapeutics.
Int J Obes (Lond). 2016 Jan;40(1):88-101. doi: 10.1038/ijo.2015.170. Epub 2015 Aug 27.
10
Circulating microRNAs and diabetes: potential applications in medical practice.
Diabetologia. 2015 Sep;58(9):1978-92. doi: 10.1007/s00125-015-3680-y. Epub 2015 Jul 9.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验